Science Market Update

Texas Medical Center Pioneers New Brain Cancer Treatment

Posted by Rebecca Partridge on Wed, Jan 18, 2017

Researchers at Texas Medical Center’s (TCM) Houston Methodist Hospital have invented a way to overcome chemotherapy drug resistance and destroy the deadliest type of brain tumors without destroying the surrounding tissue. This targeted approach combines a “smart drug” with chemotherapy. In animal models of human brain cancer, this smart drug prolonged life by over six fold.

Read More

Tags: cancer research, Texas Medical Center, Cancer, tmc, Biotechnology Vendor Fair, cancer therapy, Bioresearch Grant, Biotechnology trade show

WashU Receives $10M for Research on Immune-Based Therapies

Posted by Emily Olson on Wed, Nov 02, 2016

The $10 million gift from Andrew M. and Jane M. Bursky will advance cutting-edge research at the newly named Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. Research at the center focuses on harnessing the immune system to fight cancer, infectious diseases, and autoimmune disorders.

Read More

Tags: Washington University, Missouri, Washington University in St. Louis, new research funding, cancer research, infectious diseases, Immune System, MO, Midwest Region, immune system research, Washington Univsersity St. Louis, cancer therapy

Breast Cancer Research Breakthrough at UI Urbana-Champaign

Posted by Rebecca Partridge on Wed, Oct 12, 2016

According to the American Cancer Society, 1 in 8 American women will develop invasive breast cancer in their lifetime, and each year over 40,000 women die from it. However, thanks to research conducted at the University of Illinois Urbana-Champaign, the number of deaths due to breast cancer may soon be significantly reduced. 

Read More

Tags: breast cancer research, University of Illinois Urbana-Champaign, cancer research, Cancer Treatment, Cancer, UI Urbana, Midwest Region, UIUC, cancer therapy

Cancer Fighting Antibody Created by Duke Researchers

Posted by Laura Braden on Fri, Jun 10, 2016

Antibodies are essential for keeping the body healthy, as they are produced in the immune system and sent to fight harmful substances. Since they are essential for fighting off unwanted antigens in the body, antibodies are a hot topic that researchers are constantly studying. Recently, a research team from Duke University developed an antibody that specifically targets cancer cells, providing a possible new immunotherapy for cancer. (Image of antibody-antigen complex courtesy of Alejandro Porto via Wikimedia Commons)

Read More

Tags: Duke University, cancer research, Durham, NC, Duke, Antibodies, BioResearch Product Faire, cancer therapy, eastern, CFH

UChicago and Evelo Biosciences to Develop New Cancer Immunotherapy

Posted by Laura Braden on Wed, Jun 08, 2016

Researchers around the world are constantly studying ways to create new treatment methods to fight cancer. With so many different forms of cancer, using one treatment method is not always effective for everyone battling this disease. Recently, a team of scientists in Chicago teamed up to create a new treatment method. Researchers from the University of Chicago and the biotechnology company Evelo Biosciences have partnered to develop a new microbiome-based immunotherapy treatment method for fighting cancer. 

Read More

Tags: Midwest, microbiome, immunotherapy, University of Chicago, cancer research, Chicago, Front Line event, IL, UChicago, 2016, BioResearch Product Faire, cancer therapy, Evelo Biosciences, microbiome immunotherapy

Harvard and Merck Partner for $20M Cancer Therapeutics Research

Posted by Laura Braden on Mon, Apr 18, 2016

Acute myeloid leukemia (AML) is the most common form of leukemia affecting the blood and bone marrow, and has been responsible for 1.8% of cancer deaths in 2016. Because it is so prevalent, many research teams around the world study this disease in search of new treatment methods. One of these research teams, from Harvard University, has joined up with the pharmaceutical company Merck in a $20 million collaboration to develop new therapeutics for leukemia.

Read More

Tags: Harvard University, Northeast, Leukemia, cancer research, Massachusetts, Boston, BioResearch Product Faire Event, MA, Harvard, longwood, 2016, cancer therapy, Merck

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!